60
Participants
Start Date
January 1, 2024
Primary Completion Date
June 1, 2024
Study Completion Date
August 1, 2024
Memantine Hydrochloride
Memantine was added to each patient's current medication, with the initial dosage of 5 mg/day (once daily). The dosage was then increased to 10 mg/day after a week and maintained till the end of the study. In the case of intolerance to this increase, the dosage was flexibly adjusted according to the condition of the patient.
Assiut University, Faculty of Medicine, Hospital of Neurology, Psychiatry and Neurosurgery, Asyut
Assiut University
OTHER